ticagrelor
NDC 77771-521, ticagrelor, tablet, from Radha Pharmaceuticals INC.
- Product NDC
- 77771-521
- Status
- Listed
- Labeler
- Radha Pharmaceuticals INC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218962
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/77771-521 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TICAGRELOR60 mg/1
Pharmacologic classes
Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; P-Glycoprotein Inhibitors [MoA]; P2Y12 Platelet Inhibitor [EPC]; P2Y12 Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 77771-521-60 | 77771052160 | 60 TABLET in 1 BOTTLE (77771-521-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/436d1bef-da01-7d0a-e063-6294a90abd90
Use it
Look up 77771-521 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/77771-521 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 77771-521. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.